FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2128601920> ?p ?o ?g. }

• W2128601920 endingPage "710" @default.
• W2128601920 startingPage "700" @default.
• W2128601920 abstract "PURPOSE: The matrix metalloproteinases and their inhibitors are known to be involved in the process of tumor invasion and progression. Our objective was to investigate the potential diagnostic and prognostic value of plasma matrix metalloproteinase-2 and -9 and tissue inhibitor of metalloproteinase-1 in colorectal cancer. METHODS: Gelatinase bioactivity and immunoreactivity of pro-matrix metalloproteinase-2 and -9, tissue inhibitor of metalloproteinase-1, and carcinoembryonic antigen were determined simultaneously in preoperative plasma and serum of colorectal cancer patients (n = 94) and in healthy controls (n = 51). RESULTS: Plasma pro-matrix metalloproteinase-2 levels were lower in colorectal cancer patients (P< 0.0001) than in controls, and its gelatinolytic activity revealed an inverse correlation with adverse clinicopathologic parameters, such as lymph node involvement (P= 0.017), stage (0, I, II vs. III, IV;P= 0.012), and the carcinoembryonic antigen level (P= 0.016). Pro-matrix metalloproteinase-9 levels did not differ between patients and controls. Pro-matrix metalloproteinase-2 gelatinolytic activity showed potential value in colorectal cancer diagnosis, identifying patients with 70 percent sensitivity at 95 percent specificity. Pro-matrix metalloproteinase-9, tissue inhibitor of metalloproteinase-1, and carcinoembryonic antigen all showed lower sensitivities. Combining pro-matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-1 measurements increased the sensitivity significantly to 84 percent. With respect to prognosis, tissue inhibitor of metalloproteinase-1 showed value in predicting disease outcome in our patient group, whereas pro-matrix metalloproteinase-2 and -9 did not. The combination of tissue inhibitor of metalloproteinase-1 and carcinoembryonic antigen was better in predicting three-year survival than tissue inhibitor of metalloproteinase-1 alone, but it remains to be determined if the combination would be a better marker for survival than carcinoembryonic antigen alone. CONCLUSIONS: Low pro-matrix metalloproteinase-2 levels and high tissue inhibitor of metalloproteinase-1 levels correlate with parameters of colorectal cancer disease. These correlations may be used in the search for new markers in colorectal cancer diagnosis and prognosis." @default.
• W2128601920 created "2016-06-24" @default.
• W2128601920 creator A5048660941 @default.
• W2128601920 creator A5055814957 @default.
• W2128601920 creator A5058732622 @default.
• W2128601920 creator A5059088364 @default.
• W2128601920 date "2005-04-01" @default.
• W2128601920 modified "2023-10-13" @default.
• W2128601920 title "Plasma Levels of Matrix Metalloproteinase-2 and Tissue Inhibitor of Metalloproteinase-1 Correlate With Disease Stage and Survival in Colorectal Cancer Patients" @default.
• W2128601920 cites W1216920744 @default.
• W2128601920 cites W1503337666 @default.
• W2128601920 cites W1588950918 @default.
• W2128601920 cites W1964855331 @default.
• W2128601920 cites W1965876379 @default.
• W2128601920 cites W1969101538 @default.
• W2128601920 cites W1970839747 @default.
• W2128601920 cites W1975990293 @default.
• W2128601920 cites W1979390430 @default.
• W2128601920 cites W1993275040 @default.
• W2128601920 cites W1997588799 @default.
• W2128601920 cites W2004101410 @default.
• W2128601920 cites W2005707246 @default.
• W2128601920 cites W2015753590 @default.
• W2128601920 cites W2051140830 @default.
• W2128601920 cites W2060848035 @default.
• W2128601920 cites W2060989943 @default.
• W2128601920 cites W2061876562 @default.
• W2128601920 cites W2074336818 @default.
• W2128601920 cites W2078128814 @default.
• W2128601920 cites W2088479573 @default.
• W2128601920 cites W2089726055 @default.
• W2128601920 cites W2104692426 @default.
• W2128601920 cites W2119050264 @default.
• W2128601920 cites W2130453040 @default.
• W2128601920 cites W2146031669 @default.
• W2128601920 cites W2147894248 @default.
• W2128601920 cites W2152487395 @default.
• W2128601920 cites W2154401382 @default.
• W2128601920 cites W2167707235 @default.
• W2128601920 cites W2169063460 @default.
• W2128601920 cites W2328176404 @default.
• W2128601920 doi "https://doi.org/10.1007/s10350-004-0854-y" @default.
• W2128601920 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/15906450" @default.
• W2128601920 hasPublicationYear "2005" @default.
• W2128601920 type Work @default.
• W2128601920 sameAs 2128601920 @default.
• W2128601920 citedByCount "70" @default.
• W2128601920 countsByYear W21286019202012 @default.
• W2128601920 countsByYear W21286019202013 @default.
• W2128601920 countsByYear W21286019202014 @default.
• W2128601920 countsByYear W21286019202015 @default.
• W2128601920 countsByYear W21286019202016 @default.
• W2128601920 countsByYear W21286019202017 @default.
• W2128601920 countsByYear W21286019202018 @default.
• W2128601920 countsByYear W21286019202019 @default.
• W2128601920 countsByYear W21286019202020 @default.
• W2128601920 countsByYear W21286019202021 @default.
• W2128601920 countsByYear W21286019202022 @default.
• W2128601920 crossrefType "journal-article" @default.
• W2128601920 hasAuthorship W2128601920A5048660941 @default.
• W2128601920 hasAuthorship W2128601920A5055814957 @default.
• W2128601920 hasAuthorship W2128601920A5058732622 @default.
• W2128601920 hasAuthorship W2128601920A5059088364 @default.
• W2128601920 hasConcept C109523444 @default.
• W2128601920 hasConcept C121608353 @default.
• W2128601920 hasConcept C126322002 @default.
• W2128601920 hasConcept C142724271 @default.
• W2128601920 hasConcept C143998085 @default.
• W2128601920 hasConcept C2775958869 @default.
• W2128601920 hasConcept C2775965246 @default.
• W2128601920 hasConcept C2777387746 @default.
• W2128601920 hasConcept C502942594 @default.
• W2128601920 hasConcept C526805850 @default.
• W2128601920 hasConcept C55728118 @default.
• W2128601920 hasConcept C71924100 @default.
• W2128601920 hasConcept C90924648 @default.
• W2128601920 hasConceptScore W2128601920C109523444 @default.
• W2128601920 hasConceptScore W2128601920C121608353 @default.
• W2128601920 hasConceptScore W2128601920C126322002 @default.
• W2128601920 hasConceptScore W2128601920C142724271 @default.
• W2128601920 hasConceptScore W2128601920C143998085 @default.
• W2128601920 hasConceptScore W2128601920C2775958869 @default.
• W2128601920 hasConceptScore W2128601920C2775965246 @default.
• W2128601920 hasConceptScore W2128601920C2777387746 @default.
• W2128601920 hasConceptScore W2128601920C502942594 @default.
• W2128601920 hasConceptScore W2128601920C526805850 @default.
• W2128601920 hasConceptScore W2128601920C55728118 @default.
• W2128601920 hasConceptScore W2128601920C71924100 @default.
• W2128601920 hasConceptScore W2128601920C90924648 @default.
• W2128601920 hasIssue "4" @default.
• W2128601920 hasLocation W21286019201 @default.
• W2128601920 hasLocation W21286019202 @default.
• W2128601920 hasOpenAccess W2128601920 @default.
• W2128601920 hasPrimaryLocation W21286019201 @default.
• W2128601920 hasRelatedWork W2027146490 @default.
• W2128601920 hasRelatedWork W2056807329 @default.
• W2128601920 hasRelatedWork W2075649552 @default.
• W2128601920 hasRelatedWork W2088172329 @default.

• next